Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer

OBJECTIVE: The primary objective of this study was to evaluate the safety of niraparib 300 mg/day in Japanese patients with platinum-sensitive, relapsed ovarian cancer in a maintenance setting. METHODS: Phase 2, multicenter, open-label, single-arm study enrolled Japanese patients with platinum-sensi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gynecol Oncol
Autori principali: Takehara, Kazuhiro, Matsumoto, Takashi, Hamanishi, Junzo, Hasegawa, Kosei, Matsuura, Motoki, Miura, Kiyonori, Nagao, Shoji, Nakai, Hidekatsu, Tanaka, Naotake, Tokunaga, Hideki, Ushijima, Kimio, Watari, Hidemichi, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Suri, Ajit, Itamochi, Hiroaki, Takeshima, Nobuhiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930455/
https://ncbi.nlm.nih.gov/pubmed/33470063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e21
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi